ASHLEY MARTINEZ: Open Payments
NPI 1497412308 · SOUTH MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,181 in 143 payments from 15 companies in 2025. Trend: 2023 $2,500 · 2024 $2,717 · 2025 $3,181
Food & beverage: $3,181
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 22 | $640 |
| ABBVIE INC. | 36 | $467 |
| Indivior Inc. | 12 | $424 |
| Otsuka America Pharmaceutical, Inc. | 16 | $399 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $307 |
| E.R. Squibb & Sons, L.L.C. | 8 | $179 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $176 |
| Alkermes, Inc. | 9 | $144 |
| Almatica Pharma LLC | 5 | $125 |
| Janssen Pharmaceuticals, Inc | 4 | $96 |
Products named: Auvelity, VRAYLAR, REXULTI, SUBLOCADE, CAPLYTA, TRINTELLIX, COBENFY, ARISTADA.
Industry payments across FL — which companies pay providers there.
